Ciaramella Giuseppe 4

What Happened
Giuseppe Ciaramella, President of Beam Therapeutics (BEAM), was granted 80,000 shares as a derivative award on January 31, 2026. The Form 4 records the transaction as an award/grant (code A) at $0.00 per share, indicating a compensation grant rather than a cash purchase or sale.

Key Details

• Transaction date: 2026-01-31; Form 4 filed: 2026-02-02 (appears timely).
• Amount granted: 80,000 (derivative award recorded at $0.00).
• Vesting: Vests in equal monthly installments over the following 48 months, subject to continued service (footnote).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Transaction type: Award/grant of stock option (not a market purchase or sale).

Context
This filing documents a compensation-related stock option grant that vests over four years. Such grants are common for executives and are part of pay/retention programs; they do not represent an immediate market purchase or sale of shares and therefore are not a direct signal of buying or selling intent.